Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01159535 · ClinicalTrials.gov registry record · Phase 1
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
A Phase 1 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 286
- Enrollment target
NCT01159535: Completed Phase 1 study, sponsored by University of Washington.
NCT01159535 is a Phase 1 study that has completed, run by University of Washington. The registered enrollment target is 286 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (377% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01159535, a Phase 1 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 286 participants
- Enrollment target
Study Summary
The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol and other drug (AOD) use disorders in preventing AOD relapse compared to treatment as usual (TAU) offered in the community. The two cognitive-behavioral aftercare treatments are relapse prevention (RP) and Mindfulness-Based Relapse Prevention (MBRP), which integrates mindfulness meditation and RP aftercare components.
Primary Outcome
Self reported use of alcohol and or illicit substances over the previous 30 days
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Relapse Prevention
- BEHAVIORAL Mindfulness Based Relapse Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
What the finished NCT01159535 record still lists
NCT01159535 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (377% higher).
The record links to 0 conditions, and to 3 interventions - of which Treatment as Usual is the first listed.
NCT01159535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01159535 about?
NCT01159535 is a clinical study titled "Mindfulness Based Relapse Prevention: Efficacy and Mechanisms". The broad, long-term objective of the proposed randomized clinical trial is to evaluate the efficacy, moderators and mechanisms of change of two cognitive-behavioral aftercare treatments for alcohol and other drug (AOD) use disorders in preventing AOD relapse compared to treatment as usual (TAU) off...
What is the current status of trial NCT01159535?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 286 participants. The study started on 2009-10. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01159535?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Relapse Prevention (BEHAVIORAL), Mindfulness Based Relapse Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01159535?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01159535's enrollment target sits among peer trials
286 139th of 2000 higher than 1,862 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia